Trials / Unknown
UnknownNCT04430088
Phase 3 Efficacy and Safety Study of VVZ-149 Injections for Postoperative Pain Following Bunionectomy
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Postoperative Pain Following Bunionectomy
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Vivozon, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this phase 3 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections for treating post-operative pain following bunionectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VVZ-149 Injections | IV infusion of 1000 mg of VVZ-149 |
| DRUG | Placebo | IV infusion of 0 mg of VVZ-149 |
Timeline
- Start date
- 2020-06-26
- Primary completion
- 2020-12-01
- Completion
- 2021-01-01
- First posted
- 2020-06-12
- Last updated
- 2020-07-23
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04430088. Inclusion in this directory is not an endorsement.